• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?

作者信息

Mitin Timur, Henry Ann, Choudhury Ananya, Chen Ronald C, Pinkawa Michael, Spratt Daniel E

机构信息

Knight Cancer Institute, Oregon Health and Science University, Department of Radiation Medicine, Portland, Oregon.

Radiotherapy Research Group, University of Leeds, Leeds, United Kingdom.

出版信息

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):618-620. doi: 10.1016/j.ijrobp.2019.07.008.

DOI:10.1016/j.ijrobp.2019.07.008
PMID:31540596
Abstract
摘要

相似文献

1
SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?局部前列腺癌的立体定向体部放疗：它准备好腾飞了吗？
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):618-620. doi: 10.1016/j.ijrobp.2019.07.008.
2
Extreme Hypofractionation with SBRT in Localized Prostate Cancer.局限性前列腺癌的 SBRT 超分割放疗。
Curr Oncol. 2021 Aug 3;28(4):2933-2949. doi: 10.3390/curroncol28040257.
3
Stereotactic body radiation therapy for prostate cancer-a review.前列腺癌的立体定向体部放射治疗——综述
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S10. doi: 10.21037/cco.2017.06.05.
4
Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer.
BJU Int. 2023 Dec;132(6):648-650. doi: 10.1111/bju.16151. Epub 2023 Aug 21.
5
Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate Cancer.立体定向体部放射治疗高危、极高危和淋巴结阳性前列腺癌的超分割早期结果。
Clin Oncol (R Coll Radiol). 2018 Jul;30(7):442-447. doi: 10.1016/j.clon.2018.03.004. Epub 2018 Mar 21.
6
How will the CHHiP trial affect the future of prostate radiotherapy?CHHiP试验将如何影响前列腺癌放疗的未来？
Expert Rev Anticancer Ther. 2018 Jul;18(7):607-609. doi: 10.1080/14737140.2018.1477595. Epub 2018 May 25.
7
[Moderate or extreme hypofractionation and localized prostate cancer: The times are changing].[适度或极度超分割与局限性前列腺癌：时代在变]
Cancer Radiother. 2019 Oct;23(6-7):503-509. doi: 10.1016/j.canrad.2019.07.139. Epub 2019 Aug 27.
8
Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet.我们准备好使用大分割放疗而非传统放疗来治疗前列腺癌了吗？还没有。
Int Braz J Urol. 2019 Jan-Feb;45(1):5-9. doi: 10.1590/S1677-5538.IBJU.2018.0734.
9
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.单次放疗治疗局限性前列腺癌：一项单臂、多中心 I/II 期试验的研究方案。
Radiat Oncol. 2018 Sep 4;13(1):166. doi: 10.1186/s13014-018-1112-0.
10
PROshot: Internal Mammary Coverage, Dose-Reduced Radiation After Transoral Surgery, Sequencing of Total Neoadjuvant Therapy for Rectal Cancer, Hypofractionated Whole Breast Intensity Modulated Radiation Therapy, Hypofractionated Prostate Fossa Radiation Therapy, and Stereotactic Body Radiation Therapy for Oligoprogressive Cancer.PROshot：内乳覆盖、经口手术后剂量降低的放疗、直肠癌全新辅助治疗的序贯治疗、大分割全乳调强放疗、大分割前列腺窝放疗以及寡进展性癌的立体定向体部放疗
Pract Radiat Oncol. 2022 Mar-Apr;12(2):79-83. doi: 10.1016/j.prro.2021.12.010.

引用本文的文献

1
Clinical Experience and Feasibility of Using 2D-kVimage Online Intervention in the Ultrafractionated Stereotactic Radiation Treatment of Prostate Cancer.使用 2D-kVimage 在线干预技术进行超分割立体定向放射治疗前列腺癌的临床经验和可行性。
Pract Radiat Oncol. 2023 May-Jun;13(3):e308-e318. doi: 10.1016/j.prro.2022.10.014. Epub 2022 Dec 5.
2
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?评估每日 MR 引导前列腺床放射治疗期间阴茎球部大小和位置的分次变化：我们是否需要调整放射治疗计划以降低前列腺根治术后勃起功能障碍的风险？
Clin Genitourin Cancer. 2022 Jun;20(3):e227-e232. doi: 10.1016/j.clgc.2022.01.006. Epub 2022 Jan 11.
3
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.基于倾向性评分的 SBRT 与常规放疗治疗中危前列腺癌的生存分析。
Clin Genitourin Cancer. 2022 Apr;20(2):123-131. doi: 10.1016/j.clgc.2021.11.012. Epub 2021 Dec 1.
4
Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma.评估将超分割术前放射治疗作为肉瘤标准治疗方案的阈值
Sarcoma. 2021 Oct 26;2021:3735874. doi: 10.1155/2021/3735874. eCollection 2021.
5
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.立体定向体部放疗治疗前列腺癌的剂量反应：前列腺特异性抗原动力学和生化控制的多机构分析。
Radiother Oncol. 2021 Jan;154:207-213. doi: 10.1016/j.radonc.2020.09.053. Epub 2020 Oct 7.
6
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).雄激素剥夺疗法、外照射放疗和立体定向体部放疗治疗高危前列腺癌的 I/IIa 期试验（ADEBAR）。
Radiat Oncol. 2020 Oct 8;15(1):234. doi: 10.1186/s13014-020-01665-6.
7
Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer.立体定向体部放疗与常规/中分割放射治疗联合雄激素剥夺疗法治疗预后不良的前列腺癌。
Radiat Oncol. 2020 Sep 15;15(1):217. doi: 10.1186/s13014-020-01658-5.